Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients

NCT04920500 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Daunorubicin Cytarabine liposome for injection
DRUG: Vyxeos、Daunorubicin Cytarabine liposome for injection

Sponsor

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.